BICO Group
35,86
SEK
-5,13 %
Mindre end 1K følgere
BICO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
-5,13%
-10,97%
+16,66%
+11,99%
-10,35%
-15,46%
-80,21%
-61,81%
+163,19%
BICO Group operates in the biotechnology industry and focuses on the development and manufacturing of technologies for cell-based research and medical development. The company's products are aimed at researchers and pharmaceutical companies. The business is global with a main presence in Europe, North America and Asia. BICO Group was founded in 2016 and is headquartered in Gothenburg, Sweden.
Læs mereMarkedsværdi
2,53 mia. SEK
Aktieomsætning
7,15 mio. SEK
Omsætning
1,95 mia.
EBIT %
-14,85 %
P/E
-
Udbytteafkast, %
-
Finanskalender
29.4
2025
Delårsrapport Q1'25
8.5
2025
Generalforsamling '25
19.8
2025
Delårsrapport Q2'25
Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Correction: Notice to attend Annual General Meeting in BICO Group AB (publ)
Notice to attend Annual General Meeting in BICO Group AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
BICO has entered into an agreement to divest MatTek to Sartorius for USD 80m

BICO, Audiocast with teleconference, Q1'25
BICO Publishes Annual and Sustainability Report 2024

BICO, Audiocast with teleconference, Q4'24
Publication of BICO Group AB: Year-end report 2024
BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 276m
Invitation to the presentation of BICO’s Year-end report 2024
BICO completes the divestment of Nanoscribe
